UNEEG™ medical A/S has a core team of corporate officers and managers. Between them, the core team possesses high competencies within the areas of: neuroscience, diabetes, data analysis, medical device development, project management, regulatory affairs, clinical trials, sales and marketing.

The core team works in close collaboration with a large number of stakeholders, all of whom are in possession of critical insight within a specific discipline.

These stakeholders include: Scientific Advisory Boards, a number of participating hospitals, a technology network, and major business partners within design and production.



Torben Sandgren is Chief Executive Officer at UNEEG™ medical A/S which is a part of the Widex Group. He joined the company in 2018. Torben has a track record of driving growth and innovation in major global healthcare companies across a number of medical device specialities including diabetes, Parkinson Disease, Ostomy, Advanced Wound Care, Urology as well as a number of specialities within general surgery.

Torben came from a position as Global Vice President, Sales, Marketing and R&D/IPR in ConvaTec Group Plc / Unomedical A/S. Prior to ConvaTec, he has held international leadership roles in Coloplast A/S and BP/Castrol Oil in Denmark and Austria. Torben holds a B. Com in Marketing Economics from Copenhagen Business School.


Lars Trolle is Chief Development Officer (CDO) and VP Operations. Lars contributes with more than 25 years of senior management experience within the medical device industry.

Prior to joining UNEEG™ medical, Lars held the position as Managing Director of Contura International A/S, a leading company within the implantable hydrogel business and before that, similar position of DDD-Diagnostic A/S (Nuclear Medicine imaging solutions). Lars has previously held global positions in manufacturing, technology and development at Unomedical A/S (former Maersk Medical A/S). Lars holds a B.Sc. in Mechanical Engineering and a Bachelor of Commerce in Organization and Strategy from Copenhagen Business School.


Steen Hesthaven joined UNEEG™ medical A/S as Chief Commercial Officer (CCO) in 2018. Steen comes with 20 years of international commercial experience from the medical device industry within a broad range of specialities - including single-use endoscopy, neurology, anaesthesia, ostomy and clinical microbiology.

Before joining UNEEG™ medical, Steen held the position as Vice President, Corporate Marketing and member of the global management team at Ambu A/S. He has previously held international leadership positions in sales, marketing and product management at Coloplast A/S and AdvanDx A/S (later acquired by OpGen, Inc.).Steen holds an M.Sc. degree in International Business from Copenhagen Business School.


  • Søren Westerman, Chairman and Co-owner of WS Audiology (“Widex-Sivantos”) and T&W Medical A/S
  • Prof. Henning Beck-Nielsen (M.D.), Vice-chair and Co-founder of UNEEG™ medical A/S
  • Lars Nørgaard, CEO of T&W Medical A/S
  • Richard Tøpholm, CTO at UNEEG™ medical A/S and Co-owner of T&W Medical A/S
  • Philip Just Larsen, Senior Vice President, Global Head of Research at Bayer Pharmaceuticals
  • Peter Willems-Alnøe, Former CEO of VICARE MEDICAL A/S
  • Henrik Skak Bender (board alternate), CFO at WS Audiology A/S
  • Rasmus Stig Jensen (board alternate), Co-founder and management consultant


  •  Torben Sandgren, CEO at UNEEG™ medical A/S